Phase 1 Study Results of GS-5718, an Oral IRAK4-Inhibitor: Pharmacodynamics of Single and Multiple Doses of GS-5718 in Healthy Subjects

被引：0
|
作者：
Roedder, Silke [1 ]
Wendt, Emily [2 ]
Burris, Chad [2 ]
Nazareon, Jonathan [2 ]
Park, Grace [3 ]
Pangilinan, Phil [2 ]
Huang, Gianna [2 ]
Mathur, Anubhav [2 ]
Taylor, James [2 ]
Billin, Andrew [2 ]
Matzkies, Franziska [4 ]
机构：
[1] Gilead Sci, Menlo Pk, CA USA
[2] Gilead Sci, Foster City, CA USA
[3] Gilead Sci, Seattle, WA USA
[4] Gilead Sci Inc, Foster City, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0185
引用
收藏
页码：371 / 372
页数：2
相关论文
共 50 条
  • [41] Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in healthy subjects
    Callahan, Michael
    Treston, Anthony M.
    Lin, Grace
    Smith, Marla
    Kaufman, Brian
    Khaliq, Mansoora
    DeWald, Lisa Evans
    Spurgers, Kevin
    Warfield, Kelly L.
    Lowe, Preeya
    Duchars, Matthew
    Sampath, Aruna
    Ramstedt, Urban
    PLOS NEGLECTED TROPICAL DISEASES, 2022, 16 (08):
  • [42] First-in-human results from a phase 1 single- and multiple-ascending dose study in healthy participants assessing the safety, pharmacokinetics, and pharmacodynamics of the interleukin-17A inhibitor JNJ-81241459
    Ling, I.
    Leung, M.
    Piantone, A.
    Sinha, V.
    Song, D.
    Scott, B.
    Pryor, M.
    Verbruggen, K.
    La, D.
    Tikhonov, I.
    Ceulemans, K.
    Nischal, S.
    Polak, M.
    Eidam, P.
    Goldberg, S.
    Rao, R.
    Yang, Y-W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S375 - S375
  • [43] A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled GDC-0214, a JAK1 Inhibitor, as Single- and Multiple-Ascending Doses in Healthy Volunteers
    Owen, Ryan
    Galanter, Joshua
    Zhu, Rui
    Cai, Fang
    Tom, Jennifer
    Wynne, Chris
    Durk, Matthew
    Chen, Liuxi
    Kenny, Jane
    She, Gao-hong
    Vadhavkar, Shweta
    Hwang, Olivia
    Chen, Hubert
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB17 - AB17
  • [44] SINGLE AND MULTIPLE-DOSE IV AND ORAL PHARMACOKINETICS (PK) OF THE HEDGEHOG PATHWAY INHIBITOR GDC-0449 DURING A PHASE 1 STUDY IN HEALTHY FEMALE
    Graham, R. A.
    Hop, C. E.
    Lum, B. L.
    Colburn, D.
    Chang, I.
    Shin, Y.
    Malhi, V.
    Xie, M.
    Low, J. A.
    Dresser, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S78 - S78
  • [45] Single and Multiple Dose Pharmacokinetics, Pharmacodynamics and Safety of the Novel Lipoprotein-Associated Phospholipase A2 Enzyme Inhibitor Darapladib in Healthy Chinese Subjects: An Open Label Phase-1 Clinical Trial
    Hu, Chaoying
    Tompson, Debra
    Magee, Mindy
    Chen, Qian
    Liu, Yan Mei
    Zhu, Wenjing
    Zhao, Hongxin
    Gross, Annette S.
    Liu, Yun
    PLOS ONE, 2015, 10 (10):
  • [46] MORF-057, an oral selective α4β7 integrin inhibitor for Inflammatory Bowel Disease, leads to specific target engagement in a single and multiple ascending dose study in healthy subjects
    Ray, A.
    Cui, D.
    Lee, D.
    Mangada, M. M.
    Jones, J.
    Bain, G.
    Traber, P. G.
    Vrishabhendra, L. H.
    Krzeski, P. W.
    Vande Casteele, N.
    Reardon, M. M.
    Stern, T. P.
    Soo, C. L.
    Nguyen, H.
    Rogers, B. N.
    Linde, P. G.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S333 - S335
  • [47] A First-in-Human Single- and Multiple-Ascending Dose Study Evaluating Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Oral Nonpeptide GLP-1 Receptor Agonist in Healthy Subjects
    Pratt, Edward J.
    Ma, Xiaosu
    Liu, Rong
    Robins, Deborah A.
    Sloop, Kyle
    Benson, Charles
    DIABETES, 2022, 71
  • [48] A Randomized, Double-Blind, Placebo-Controlled, Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of CB03-154 in Healthy Subjects
    Zhu, Minjuan
    Hua, Bo
    Li, Baini
    Guo, Ruoling
    Liu, Gang
    Liu, Xiuxiu
    Wan, Hui
    Yao, Shuran
    Song, Chao
    Dou, Jinhui
    Zhang, Xin
    Lu, Zhihong
    Zhou, Xiaolin
    Chen, Huanming
    Gonen, Ofer
    ANNALS OF NEUROLOGY, 2024, 96 : S179 - S180
  • [49] Multiple Rising Doses of Oral BI 425809, a GlyT1 Inhibitor, in Young and Elderly Healthy Volunteers: A Randomised, Double-Blind, Phase I Study Investigating Safety and Pharmacokinetics
    Viktoria Moschetti
    Christina Schlecker
    Sven Wind
    Sophia Goetz
    Holger Schmitt
    Armin Schultz
    Karl-Heinz Liesenfeld
    Glen Wunderlich
    Michael Desch
    Clinical Drug Investigation, 2018, 38 : 737 - 750
  • [50] Multiple Rising Doses of Oral BI 425809, a GlyT1 Inhibitor, in Young and Elderly Healthy Volunteers: A Randomised, Double-Blind, Phase I Study Investigating Safety and Pharmacokinetics
    Moschetti, Viktoria
    Schlecker, Christina
    Wind, Sven
    Goetz, Sophia
    Schmitt, Holger
    Schultz, Armin
    Liesenfeld, Karl-Heinz
    Wunderlich, Glen
    Desch, Michael
    CLINICAL DRUG INVESTIGATION, 2018, 38 (08) : 737 - 750
12345